These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31642863)

  • 41. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attention Deficit Hyperactivity Disorder in Athletes.
    Ciocca M
    Clin Sports Med; 2019 Oct; 38(4):545-554. PubMed ID: 31472765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
    Barkley RA; Fischer M; Smallish L; Fletcher K
    Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adverse effects of stimulant medications in children and adolescents: focus on drug abuse.
    Greydanus DE; Cates KW; Sadigh N
    Int J Adolesc Med Health; 2019 Sep; 31(4):. PubMed ID: 31483757
    [No Abstract]   [Full Text] [Related]  

  • 46. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
    Levy F
    Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
    [No Abstract]   [Full Text] [Related]  

  • 47. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants.
    Ghanizadeh A
    Acta Ophthalmol; 2010 Mar; 88(2):e56. PubMed ID: 19508459
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical management of attention deficit hyperactivity disorder.
    Voeller KK
    J Child Neurol; 1991; 6 Suppl():S51-67. PubMed ID: 1672134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder.
    Shaw P
    JAMA; 2016 May; 315(18):1953-5. PubMed ID: 27163984
    [No Abstract]   [Full Text] [Related]  

  • 50. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.
    Noorbala AA; Akhondzadeh S
    Arch Iran Med; 2006 Oct; 9(4):374-80. PubMed ID: 17061613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is ADHD a valid diagnosis in adults? No.
    Moncrieff J; Timimi S
    BMJ; 2010 Mar; 340():c547. PubMed ID: 20348183
    [No Abstract]   [Full Text] [Related]  

  • 52. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
    Hoekstra PJ; Buitelaar JK
    Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055
    [No Abstract]   [Full Text] [Related]  

  • 53. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 54. Medications for attention deficit hyperactivity disorder: cardiovascular concerns.
    Wooltorton E
    CMAJ; 2006 Jul; 175(1):29. PubMed ID: 16772535
    [No Abstract]   [Full Text] [Related]  

  • 55. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risks and benefits of available treatments for adult ADHD.
    Newcorn JH
    J Clin Psychiatry; 2011 Mar; 72(3):e12. PubMed ID: 21450148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attention-deficit/hyperactivity disorder and early-onset substance use disorders.
    Wilson JJ; Levin FR
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):751-63. PubMed ID: 16262592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attention-deficit/hyperactivity disorder psychopharmacology for college students.
    Staufer WB; Greydanus DE
    Pediatr Clin North Am; 2005 Feb; 52(1):71-84, viii. PubMed ID: 15748925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Developments in treatment.
    Levy F
    Aust N Z J Psychiatry; 2002 Aug; 36(4):477-9. PubMed ID: 12169142
    [No Abstract]   [Full Text] [Related]  

  • 60. Central auditory processing disorder and ADHD.
    Jerome L
    J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):399-400. PubMed ID: 10761339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.